Discrepancy Between Tonometric Ambulatory and Cuff-Based Office Blood Pressure Measurements in Patients With Type 1 Diabetes

Journal of Clinical Hypertension

Volumn 14, Issue 10, 2012, Pages 686-693

  Theilade, Simone ^a   Lajer, Maria ^a   Joergensen, Christel ^a   Persson, Frederik ^a   Rossing, Peter ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE CUFF; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MERCURY SPHYGMOMANOMETER; PRIORITY JOURNAL; SPHYGMOMANOMETRY; TONOMETER; TONOMETRY;

ADULT; ANALYSIS OF VARIANCE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERTENSION; MALE; MANOMETRY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; WHITE COAT HYPERTENSION;

EID: 84867097474     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2012.00689.x     Document Type: Article

References (40)

1. Parving HH, Andersen AR, Smidt UM, et al. Diabetic nephropathy and arterial hypertension. Diabetologia. 1983;24:10-12.
2. Nielsen S, Schmitz A, Poulsen PL, et al. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study. Diabetes Care. 1995;18:1434-1441.
3. Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57:891-897.
4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317:703-713.
5. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-419.
6. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(suppl 1):S11-S63.
7. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156-161.
8. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46:508-515.
9. Rodrigues TC, Canani LH, Viatroski RS, et al. Masked hypertension, nocturnal blood pressure and retinopathy in normotensive patients with type 1 diabetes. Diabetes Res Clin Pract. 2010;87:240-245.
10. Ng CM, Yiu SF, Choi KL, et al. Prevalence and significance of white-coat hypertension and masked hypertension in type 2 diabetics. Hong Kong Med J. 2008;14:437-443.
11. Pierdomenico SD, Lapenna D, Di MR, Cuccurullo F. Short- and long-term risk of cardiovascular events in white-coat hypertension. J Hum Hypertens. 2008;22:408-414.
12. Bursztyn M, Ben-Dov IZ. White-coat hypertension should not be treated in subjects with diabetes. Diabetes Care. 2009;32(suppl 2):S310-S313.
13. Kotsis V, Stabouli S, Toumanidis S, et al. Target organ damage in "white coat hypertension" and "masked hypertension." Am J Hypertens. 2008;21:393-399.
14. Sega R, Trocino G, Lanzarotti A, et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation. 2001;104:1385-1392.
15. Ben-Dov IZ, Ben-Ishay D, Mekler J, et al. Increased prevalence of masked blood pressure elevations in treated diabetic subjects. Arch Intern Med. 2007;167:2139-2142.
16. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88(Pt 5):2460-2470.
17. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80:1652-1659.
18. Chen CH, Nevo E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95:1827-1836.
19. Wang KL, Cheng HM, Sung SH, et al. Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study. Hypertension. 2010;55:799-805.
20. O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-848.
21. Nair D, Tan SY, Gan HW, et al. The use of ambulatory tonometric radial arterial wave capture to measure ambulatory blood pressure: the validation of a novel wrist-bound device in adults. J Hum Hypertens. 2008;22:220-222.
22. Theilade S, Joergensen C, Persson F, et al. Ambulatory tonometric blood pressure measurements in patients with diabetes. Diabetes Technol Ther. 2012;14(6):453-456.
23. Longo D, Toffanin G, Garbelotto R, et al. Performance of the UA-787 oscillometric blood pressure monitor according to the European Society of Hypertension protocol. Blood Press Monit. 2003;8:91-95.
24. Bonso E, Ragazzo F, Palatini P. Validation of A&D UA-85X device for blood pressure measurement. Blood Press Monit. 2008;13:339-341.
25. Brochner-Mortensen J, Rodbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest. 1976;36:35-43.
26. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254.
27. Almeida L, Amado P, Vasconcelos N, et al. [Is ambulatory blood pressure monitoring reliable in hypertensive patients with atrial fibrillation?]. Rev Port Cardiol. 2001;20:647-650.
28. Quaglione R, Calcagnini G, Censi F, et al. Effect of pacemaker rate-adaptation on 24 h beat-to-beat heart rate and blood pressure profiles. Europace. 2005;7:366-373.
29. Hodgkinson J, Mant J, Martin U, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.
30. Lurbe E, Redon J, Kesani A, et al. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med. 2002;347:797-805.
31. Hansen KW, Poulsen PL, Mogensen CE. Ambulatory blood pressure and abnormal albuminuria in type 1 diabetic patients. Kidney Int Suppl. 1994;45:S134-S140.
32. Astrup AS, Nielsen FS, Rossing P, et al. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J Hypertens. 2007;25:2479-2485.
33. Leitao CB, Rodrigues TC, Kramer CK, et al. Which patients with diabetes should undergo ambulatory blood pressure monitoring? J Hypertens. 2011;29:236-241.
34. Ritchie LD, Campbell NC, Murchie P. New NICE guidelines for hypertension. BMJ. 2011;343:d5644.
35. Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378:1219-1230.
36. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 2011;34:1270-1276.
37. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10-15.
38. Wilkinson IB, MacCallum H, Rooijmans DF, et al. Increased augmentation index and systolic stress in type 1 diabetes mellitus. QJM. 2000;93:441-448.
39. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829-840.
40. Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585.